Search

Author/Creator Tahara, M

1. LBA8_PRKEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). (23rd October 2018)

Authors:
Burtness, B; Harrington, K J; Greil, R; Soulières, D; Tahara, M; De Castro, G; Psyrri, A; Baste Rotllan, N; Neupane, P C; Bratland, Å; Fuereder, T; Hughes, B G M; Mesia, R; Ngamphaiboon, N; Rordorf, T; Wan Ishak, W Z; Roy, A; Cheng, J; Jin, F; Rischin, D
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 1112PNutritional support dependence after curative chemoradiotherapy in head and neck cancer: A supplementary analysis of a phase II trial (JCOG0706S1). (23rd October 2018)

Authors:
Imamura, Y; Kiyota, N; Akimoto, T; Ogawa, G; Eba, J; Minami, S; Hasegawa, Y; Iwae, S; Monden, N; Matsuura, K; Fujii, H; Onozawa, Y; Homma, A; Hayashi, R; Tahara, M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 1056PDPhase I experience with rogaratinib in patients with head and neck cancer selected based on FGFR mRNA overexpression. (23rd October 2018)

Authors:
Joerger, M; Takahashi, S; Sayehli, C M; Slosarczyk, S; Navarro Mendivil, A; Cassier, P A; Nogai, H; Zhang, C; Sei, F; Bender, S; Ellinghaus, P; Tahara, M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 309PEvaluation of a pharmacist-led opioid de-escalation (PLODE) program after chemoradiotherapy completion in head and neck cancer patients. (24th November 2019)

Authors:
Horinouchi, A; Suzuki, S; Kamata, H; Kaneko, A; Fujisawa, T; Ueda, Y; Enokida, T; Ito, K; Okano, S; Makabe, H; Kawasaki, T; Tahara, M
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. 286OPhase III KEYNOTE-048 study of first-line pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma: Asia vs non-Asia subgroup analysis. (24th November 2019)

Authors:
Ngamphaiboon, N; Tanaka, K; Hong, R-L; Wan Ishak, W Z; Yen, C-J; Sriuranpong, V; Takahashi, S; Srimuninnimit, V; Yeh, S-P; Oridate, N; Yang, M-H; Nohata, N; Koh, Y; Roy, A; Gumuscu, B; Swaby, R; Tahara, M
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. 366PActivity of larotrectinib in TRK fusion cancer patients with primary central nervous system tumours. (24th November 2019)

Authors:
Ziegler, D S; Doz, F; Geoerger, B; Dubois, S; Grilley-Olson, J E; van Tilburg, C; Italiano, A; Lissat, A; Kang, J-H; Tahara, M; Boni, V; Perreault, S; Capra, M; Nanda, S; Brega, N; Holynskyj, A; Hong, D S; Hyman, D; Drilon, A
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. T-bet over-expression regulates aryl hydrocarbon receptor-mediated T helper type 17 differentiation through an interferon (IFN)γ-independent pathway. (31st January 2017)

Authors:
Yokosawa, M; Kondo, Y; Tahara, M; Iizuka-Koga, M; Segawa, S; Kaneko, S; Tsuboi, H; Yoh, K; Takahashi, S; Matsumoto, I; Sumida, T
Journal:
Clinical and experimental immunology
Issue:
Volume 188:Number 1(2017:Apr.)
Page Start:
22
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗